Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.

Market Analysis and Insights: Global Anti-Malarial Drug Market
The global Anti-Malarial Drug market is valued at US$ 682.6 million in 2019. The market size will reach US$ 818.1 million by the end of 2026, growing at a CAGR of 2.6% during 2021-2026.

Global Anti-Malarial Drug Scope and Market Size
Anti-Malarial Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Malarial Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale

Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others

By Company
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia